U.S. Hospital and Nursing Home Probiotics Market Size, Share & Trends Analysis Report By Channel (Hospitals, Nursing Homes), By Function (Gut Health, Immunity, Wellness)- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The U.S. Hospital and Nursing Home Probiotics market size was valued at US$ 1.9 billion in 2021 and is expected to hit US$ 2.16 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.4% from 2022 to 2030.

Growth Factors:

The shift in consumer preference toward a healthier lifestyle and consequent rise in demand for preventive healthcare are anticipated to drive the U.S. market.

Innovative supplements are gaining popularity across the country owing to rising awareness regarding nutritional products. Probiotics and supplements are widely utilized to improve gut health, immunity, and overall wellness. Studies focused on uncovering the potential of probiotics and supplements are projected to help develop a wide scope for novel applications, thereby boosting the growth potential of the market.

According to the World Health Organization (WHO), 13.1 million children below the age of five died in 2020, of which 20.0% of deaths occurred due to diarrhea. Even if it does not lead to mortality, persistent diarrhea can elicit major long-term problems in infants, affecting nutrition, growth, and cognition. In 2017, among 20 developed nations, the U.S. reported the worst child mortality rate. Rising concerns regarding child mortality rate are forcing policymakers to promote the use of probiotics and supplements in nursing homes and hospitals.

The use of probiotics results in substantial cost savings for hospitals due to a reduction in various hidden costs. For institutions such as hospitals and nursing homes, reliability, and brand value are some of the most important factors for achieving a larger market share. Indirect benefits of using probiotics products allow healthcare institutions to enhance their brand image by making the hospital stay more comfortable and shorter for patients. The use of probiotics thus provides benefits to doctors, hospitals, medical staff, and patients alike.

A combination of a Letter of Medical Necessity (LMN) and a Health Reimbursement Arrangement (HRA), Health Savings Account (HSA), or Flexible Spending Account (FSA) enables consumers to claim for medical coverage. However, probiotics are ineligible for medical reimbursement with Dependent Care Flexible Spending Accounts (DCFSA) and Limited Care Flexible Spending Accounts (LCFSA).

Report Scope of the U.S. Hospital and Nursing Home Probiotics Market

Channel Insights

By channel, the industry can be segmented into hospitals and nursing homes. Hospitals emerged as the largest distribution channel with a market share of more than 69.0% in 2021. In urban areas, the ease of getting a consultation from a physician is much greater than in rural areas. The ratio of patients to primary care doctors in rural regions is 59.8 doctors per 100,000 people. Uneven distribution of doctors and poor health conditions in rural areas is an opportunity for hospitals in U.S. Probiotics suppliers and manufacturers are expected to enter the rural healthcare system owing to the presence of substantial growth potential and various untapped areas.

In the U.S., several hospitals are facing operational losses, which is pushing hospital administrations to revamp their strategies. For instance, MD Anderson Cancer Center, U.S., witnessed an operational loss of USD 266 million in 2017–2022. The hospital witnessed an additional loss of USD 170 million in early 2020. Partners HealthCare, based in Boston, U.S., suffered a loss of USD 108 million on operations in 2017–2022, which was its second operating loss in the last four years.

The operating income of Cleveland Clinic also declined by 80.0% in 2017–2022. Providence St. Joseph Health, the second-largest Catholic hospital in the U.S., registered a drop of USD 512 million in operating income along with operating loss of USD 252 million in 2017–2022. Regional players such as Northwell Health, UnityPoint Health, and California’s Sutter Health also reported a sharp decline in their operating earnings in 2017.

Hospitals must reconsider their operational and marketing strategies to overcome declining revenues. Steps must also be taken to ensure that their capital investments in emerging payment plans and physician staff generate solid returns.

Nursing homes are an important distribution channel in the U.S. hospital & nursing home probiotics market. In 2017, the segment accounted for just over 45.0% of the market. The presence of untapped markets, low penetration even in urban areas, and government support to improve the standard of nursing homes are projected to boost the segment to exhibit the fastest growth rate over the forecast period.

Function Insights

Gut health emerged as the largest and fastest-growing function of probiotics and supplements in the U.S. market. Probiotics tend to ameliorate IBS, a widely prevalent chronic disease identified by bloating, abdominal pain, and frequent constipation or diarrhea.

In U.S., probiotics, and supplements are used to reduce the risk of health issues such as NEC, AAD, lactose intolerance, and common infectious diseases (CID) such as upper respiratory tract infections, atopic dermatitis, and traveler’s diarrhea. These products are also utilized in the treatment of colic and acute infectious diarrhea. A majority of the aforementioned health problems are related to gut health, which makes it the fastest-growing segment by function.

Atopic dermatitis is the most common form of eczema in the U.S. and is primarily caused by problems associated with skin barrier and malfunctioning of the human immune system. The annual economic expenditure on eczema in the country is relatively high, as it includes various direct costs such as medication and hospital visits as well as indirect costs such as the impact of the disease on a patient’s quality of life and level of productivity. Policymakers are focusing on improving the quality of life of patients, which aids the growth of probiotics and other supplements in the U.S.

Bacteria such as Bifidobacterium longum and Lactobacillus helveticus are used to reduce depression, hostility, and anger. Apart from these functions, supplements and probiotics are also used to improve problem-solving abilities. Other functions include lung, vaginal, and skincare. Probiotics are used to treat several combined immune deficiencies (CID). Growing social awareness about nutritive products and increasing health concerns arising from busy urban lifestyles are projected to drive the market in the U.S.

U.S. Hospital & Nursing Home Probiotics Market Share Insights

Probiotics are an emerging field wherein various public and private organizations are conducting research. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have suggested only a relatively small number of diseases for which probiotics have been proven to have a remedial effect.

The strongest evidence regarding the beneficial effect of probiotics on human health has been established about B. lactis BB-12 and L. rhamnosus GG for prevention. L. reuteri SD2222 has been known to have a positive impact on acute diarrhea in children, primarily when the condition is caused by rotaviruses. The use of probiotics is a proven way to reduce the mean duration of watery diarrhea.

Several companies are engaged in partnerships and joint ventures to develop awareness about probiotic products. In January 2021, Probi, a Sweden-based probiotic B2B solution manufacturer, signed a deal with an undisclosed global FMCG company. The partnership is intended to launch and market probiotic bacteria products targeted at gut health in North America. The partnership is anticipated to boost sales and market position of Probi in this market. Some of the key companies present in the industry are Bio-K Plus International Inc.; Probi AB; Procter & Gamble; NutraScience Labs; and Probium LLC.

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at U.S. for the period of 2017 to 2030

• By Channel

• Hospital

• By Number of Beds

• 1-199
• 200-299
• 300-499
• 500+
• By Payer
• Medicare
• Medicaid
• Self-pay
• Private
• Others
• By Location
• Rural
• Urban
• Nursing home
• By Number of Beds
• Less than 50
• 50-99
• 100-199
• 199+
• By Payer
• Medicare
• Medicaid
• Dual
• By Ownership
• Government
• Profit
• Non-profit  
• By Function
• Gut Health
• Immunity
• Wellness
• Others

Key Points Covered in U.S. Hospital and Nursing Home Probiotics Market Study:

• Growth of U.S. Hospital and Nursing Home Probiotics in 2022
• Market Estimates and Forecasts (2017-2030)
• Brand Share and Market Share Analysis
• Key Drivers and Restraints Shaping Market Growth
• Segment-wise
• Competition Mapping and Benchmarking
• Recommendation on Key Winning Strategies
• COVID-19 Impact on Demand for U.S. Hospital and Nursing Home Probiotics and How to Navigate
• Key Product Innovations and Regulatory Climate
• U.S. Hospital and Nursing Home Probiotics Consumption Analysis
• U.S. Hospital and Nursing Home Probiotics Production Analysis
• U.S. Hospital and Nursing Home Probiotics and Management